1
/
of
0
FDA Drug/Biologics Approval BLA 125377 S-106, IPILIMUMAB
FDA Drug/Biologics Approval BLA 125377 S-106, IPILIMUMAB
Regular price
$49.00 USD
Regular price
Sale price
$49.00 USD
Unit price
/
per
BLA 125377 S-106
Company: BRISTOL MYERS SQUIBB
Drug Name: YERVOY
Active Ingredients: IPILIMUMAB
Strength: 3MG
Dosage Form/Route: INJECTABLE; INJECTION
Action Date: 03/25/2011
Marketing Status: Prescription
Submission Classification: ORIG-1
Company: BRISTOL MYERS SQUIBB
Drug Name: YERVOY
Active Ingredients: IPILIMUMAB
Strength: 3MG
Dosage Form/Route: INJECTABLE; INJECTION
Action Date: 03/25/2011
Marketing Status: Prescription
Submission Classification: ORIG-1
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. IMPORTANT: The FDA FOIA office operations are currently suspended. We are happy to make the request but do not know when we will receive a response. Learn more about Fast-Track Requests here.
View full details